Familial defective apolipoprotein B-100 (FDB) R3500 is an autosomal co-domi
nant disorder caused by the substitution of glutamine for arginine at amino
acid residue 3500 of the apolipoprotein B-100 gene. It is associated with
hypercholesterolaemia of varying severity, and with coronary artery disease
. Hypercholesterolaemic patients (n = 158) from Northern Ireland were scree
ned for the defect by polymerase chain reaction-mediated, site-directed mut
agenesis. Clinical presentation ranged from moderate hypercholesterolaemia
with a family history of hypercholesterolaemia or heart disease (n = 104) t
o those classified as definitely having familial hypercholesterolaemia (FH)
(n = 54). Eight (5.1%) unrelated individuals were found to be heterozygous
for the FDB R3500Q mutation, including two (3.7%) of those 54 classified c
linically as having FI-I. Treatment with HMG-CoA-reductase-inhibiting drugs
(statins) decreased total cholesterol by 22-44% and low-density lipoprotei
n cholesterol by 34-46% in all but one FDB heterozygote.